Ostermundigen, Switzerland

Andreas Tuerler

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Paul Scherrer Institut, Cern Corporation. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Tuerler. Retrieved from https://idiyas.com/inventor/andreas-tuerler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Ismaning, DE (2015)
  • Ostermundigen, CH (2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Andreas Tuerler in Radionuclide Production

Introduction

Andreas Tuerler is a notable inventor based in Ostermundigen, Switzerland. He has made significant contributions to the field of radionuclide production, holding 2 patents that focus on advancements in medical imaging and radioisotope applications.

Latest Patents

One of his latest patents is titled "Production of 43SC radionuclide and radiopharmaceuticals thereof for use in positron emission tomography." This invention details a method for producing the radionuclide Sc at commercially significant yields and specific activities suitable for radiodiagnostic agents. The method involves irradiating a solid target with a charged-particle beam, utilizing an accelerator such as a biomedical cyclotron. The patent outlines three different nuclear reactions for generating the radionuclide Sc, showcasing a comprehensive approach to radionuclide production.

Another significant patent by Tuerler is "Method for production of radioisotope preparations and their use in life science, research, medical application and industry." This invention presents a universal method for the large-scale production of high-purity radioisotopes. It combines various unit operations derived from physics and material science, allowing for both batch-wise and fully automated continuous production schemes. The radioisotopes produced are particularly suitable for creating radioisotope-labelled bioconjugates and nanoparticles.

Career Highlights

Throughout his career, Tuerler has worked with prestigious institutions such as the Paul Scherrer Institute and CERN. His work at these organizations has contributed to advancements in nuclear science and medical applications.

Collaborations

Andreas Tuerler has collaborated with notable professionals in his field, including Helge Leif Ravn and Gerd Juergen Beyer. These collaborations have further enhanced his research and innovations in radionuclide production.

Conclusion

Andreas Tuerler's contributions to radionuclide production and medical imaging are significant, showcasing his expertise and innovative spirit. His patents reflect a commitment to advancing technology in the field of radiopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…